InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Friday, 08/14/2020 8:00:09 PM

Friday, August 14, 2020 8:00:09 PM

Post# of 240
News: $APVO Aptevo Therapeutics Reports Second Quarter 2020 Financial Results

Advances Phase 1/1b Clinical Trial of APVO436 for the Treatment of Acute Myeloid Leukemia and High-Grade Myelodysplastic Syndrome; Cohort 6 Enrollment Complete Presents New Preclinical Data Showing That ALG.APV-527 has Potential for a Favorable Safety Profile Extends Cash ...

In case you are interested APVO - Aptevo Therapeutics Reports Second Quarter 2020 Financial Results
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent APVO News